Acorda Therapeutics To Present At The Lazard Capital Markets Third Annual Life Sciences Conference

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics (Nasdaq: ACOR) today announced that Ron Cohen, President & CEO, will present at the upcoming Lazard Capital Markets Third Annual Life Sciences Conference on Tuesday, November 28th at 10:30 am Eastern Standard Time (EST).

MORE ON THIS TOPIC